TCB
NVS icon

Texas Capital Bancshares’s Novartis NVS Stock Holding History

Texas Capital Bancshares’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,437
Closed -$208K – 78
2021
Q1 		$208K Sell
2,437
-26
-1% -$2.33K 0.17% 71
2020
Q4 		$233K Sell
2,463
-1,094
-31% -$95.6K 0.31% 41
2020
Q3 		$309K Hold
3,557
– – 0.43% 32
2020
Q2 		$311K Hold
3,557
– – 0.46% 29
2020
Q1 		$293K Hold
3,557
– – 0.52% 24
2019
Q4 		$337K Sell
3,557
-39
-1% -$3.5K 0.48% 36
2019
Q3 		$312K Sell
3,596
-1,258
-26% -$113K 0.51% 35
2019
Q2 		$443K Sell
4,854
-87
-2% -$7.36K 0.74% 21
2019
Q1 		$426K Sell
4,941
-20
-0.4% -$1.61K 0.78% 27
2018
Q4 		$381K Buy
4,961
+900
+22% +$70.1K 0.87% 25
2018
Q3 		$314K Hold
4,061
– – 0.66% 35
2018
Q2 		$275K Hold
4,061
– – 0.6% 42
2018
Q1 		$294K Sell
4,061
-30
-0.7% -$2.28K 0.69% 36
2017
Q4 		$308K Hold
4,091
– – 0.69% 37
2017
Q3 		$315K Sell
4,091
-345
-8% -$26.1K 0.7% 32
2017
Q2 		$332K Buy
+4,436
New +$314K 0.75% 32
2015
Q4 		– Sell
-2,980
Closed -$245K – 81
2015
Q3 		$245K Sell
2,980
-1,057
-26% -$94.1K 0.21% 77
2015
Q2 		$356K Sell
4,037
-2,283
-36% -$209K 0.24% 62
2015
Q1 		$558K Sell
6,320
-858
-12% -$76.1K 0.31% 38
2014
Q4 		$596K Buy
7,178
+156
+2% +$12.9K 0.32% 35
2014
Q3 		$592K Sell
7,022
-201
-3% -$16.3K 0.34% 27
2014
Q2 		$586K Sell
7,223
-484
-6% -$38.1K 0.37% 30
2014
Q1 		$587K Buy
7,707
+69
+0.9% +$5.03K 0.38% 33
2013
Q4 		$550K Sell
7,638
-1,011
-12% -$70.3K 0.42% 32
2013
Q3 		$595K Sell
8,649
-405
-4% -$26.8K 0.46% 25
2013
Q2 		$574K Buy
+9,054
New +$589K 0.57% 21

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Texas Capital Bancshares's NVS Position: Q2 2021 in Review

Texas Capital Bancshares sold out of Novartis (NVS) in Q2 2021, closing a stake of 2,437 shares — an estimated $208K sold.

Texas Capital Bancshares first reported a position in NVS in Q2 2013 and held it in 26 quarters. The position peaked at $596K in Q4 2014. 1,120 funds tracked by Wall St. Rank hold NVS as of Q2 2021.

  • Texas Capital Bancshares reported no remaining Novartis position as of Q2 2021 after selling out during the quarter.
  • Texas Capital Bancshares sold 2,437 Novartis shares in Q2 2021, an estimated $208K.
  • Texas Capital Bancshares first reported a position in Novartis in Q2 2013 and held it in 26 quarters.
  • Texas Capital Bancshares's Novartis position peaked at $596K in Q4 2014.
  • 1,120 funds tracked by Wall St. Rank held Novartis as of Q2 2021.

Based on Texas Capital Bancshares's 13F filing for Q2 2021, filed 6 Aug 2021.